Multimodality approach to management of stage III non-small cell lung cancer

Anthony Scarpaci; Priya Mitra; Doraid Jarrar; Gregory A Masters

doi:10.1016/j.soc.2012.12.014

Multimodality approach to management of stage III non-small cell lung cancer

Surg Oncol Clin N Am. 2013 Apr;22(2):319-28. doi: 10.1016/j.soc.2012.12.014.

Authors

Anthony Scarpaci¹, Priya Mitra, Doraid Jarrar, Gregory A Masters

Affiliation

¹ Medical Oncology, Albert Einstein Medical Center Philadelphia, Philadelphia, PA 19141, USA. apscarpaci@gmail.com

PMID: 23453337
DOI: 10.1016/j.soc.2012.12.014

Abstract

Stage III non-small cell lung cancer represents a heterogeneous group of patients who are best managed with a multidisciplinary approach, including evaluation for surgical, radiation, and chemotherapeutic options.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / therapy*
Clinical Trials as Topic
Combined Modality Therapy
Humans
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Neoplasm Staging